Pre-market
Loading markets…

Advertisement

Stocks

What's Going On With Apotex Health Corp Stock Wednesday?

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:APTX.TO

Follow APTX

Photos provided by Pexels

Apotex Health Corp's stock has seen a notable decline this week, prompted by recent corporate developments.

This week, Apotex Health Corp (APTX.TO) experienced a drop in its stock price, closing down 2.02% on Wednesday. The decline follows the announcement of a successful secondary offering, which may have influenced investor sentiment.

Advertisement

Apotex Health Corp

APTX.TO

Full stock page →

APTX.TO

Apotex Health Corp

Source:WealthAwesomeWealthAwesome
↑ $3.95 (14.36%)
76 day period
$27.50$33.59$39.67Jun 11Aug 6Sep 29

Market cap

$7.33B

52W high

$40.11

52W low

$26.01

1W change

-4.73%

Analyst Price Targets

Based on analyst covering APTX · as of Sep 23, 2026

📈

Wall Street analysts forecast APTX stock price to rise 31.5% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$41.37

+31.5% Upside

Previously C$41.23 on Sep 17, 2026

Current Price

C$31.45

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on APTX's historical volatility

HistoricalForecast68%95%
C$16.06C$22.63C$29.20C$35.77C$42.34C$48.91TodayJun 11Aug 6Sep 29Nov 11Dec 25Feb 6

30-Day Vol

44.1%

Annualized

90-Day Vol

48.8%

Annualized

Trend (90d)

-32.1%

Annualized drift

90d Mean

C$28.04

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$30.27C$26.00 – C$35.24
60 trading daysC$29.13C$23.50 – C$36.12
90 trading daysC$28.04C$21.55 – C$36.49

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Investor takeaway: Investors should consider the implications of the recent secondary offering and the stock's performance relative to its moving averages and analyst outlook. While the stock is down this week, it has shown a positive year-to-date performance, indicating some resilience in the face of recent challenges.

Apotex Health Corp's stock down 4.73% this week.

With the stock currently at C$31.45, it is trading 9.5% below its 50-day moving average and 7.7% below its 200-day moving average.

Bull case

Analysts are optimistic about Apotex Health Corp, with an average target suggesting a potential upside of 31.5%, bringing the stock to C$41.37. This reflects a bullish outlook despite the current price pressures.

Bear case

The recent secondary offering might dilute existing shares, adding to the downward pressure on the stock. Furthermore, the stock's performance below its moving averages raises concerns about its near-term strength.

Recent Price Action

Advertisement

This week, Apotex Health Corp's stock has declined by 4.73%, with a notable drop of 2.02% on Wednesday. The stock closed at C$31.45, reflecting investor reactions to the company's recent developments.

Company News

On September 18, 2026, Apotex Health Corp announced the closing of an upsized bought deal secondary offering. This move is often seen as a method for companies to raise capital, but it can also lead to concerns regarding share dilution among existing investors.

Technical Picture

Apotex Health Corp is currently trading at C$31.45, which is 9.5% lower than its 50-day moving average of C$34.75 and 7.7% below its 200-day moving average of C$34.08. The stock has a 52-week range of C$26.01 to C$40.11, indicating it is currently at 39% of its range. The latest trading volume was 495,081 shares, which is about 67% of its 20-day average volume of 735,166 shares.


Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: September 30, 2026
Last Updated: September 30, 2026

Core portfolio

Awesome Portfolio™

15.1% a year since 2017, against 9.9% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+15.1%

Awesome Portfolio™

+9.9%

S&P/TSX

+5.2 pp better a year

Total return

+260%

Awesome Portfolio™

+137%

S&P/TSX

+123 pp better than the TSX

2017-07-31 to 2026-09-17, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-17
-11.7%42.8%97.2%151.6%206.0%260.4%Jul 17Oct 19Feb 22Jun 24Sep 26

Sponsored links

Advertisement